These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1663205)

  • 1. [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
    Hostetler JS; Stevens DA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():8-10. PubMed ID: 1663205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host.
    Hostetler JS; Denning DW; Stevens DA
    Chemotherapy; 1992; 38 Suppl 1():12-22. PubMed ID: 1319310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
    Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
    Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
    Denning DW; Tucker RM; Hanson LH; Stevens DA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):602-7. PubMed ID: 2170480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with itraconazole in cryptococcosis and aspergillosis.
    Viviani MA; Tortorano AM; Langer M; Almaviva M; Negri C; Cristina S; Scoccia S; De Maria R; Fiocchi R; Ferrazzi P
    J Infect; 1989 Mar; 18(2):151-65. PubMed ID: 2540243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic fungal infections in patients with HIV disease: combating cryptococcosis and histoplasmosis.
    Kirchner JT
    Postgrad Med; 1996 Jun; 99(6):209-16. PubMed ID: 8668632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the treatment of fungal pneumonias.
    Yamada H; Kotaki H; Takahashi T
    Expert Opin Pharmacother; 2003 Aug; 4(8):1241-58. PubMed ID: 12877634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal infections in the immunocompromised host.
    Hawkins C; Armstrong D
    Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histoplasmosis: update 1998.
    Brooks JT; Wheat LJ
    AIDS Clin Care; 1998 Jan; 10(1):4-5. PubMed ID: 11365076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 19. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
    Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
    Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS; Wheat LJ; Cloud GA; Pierce M; Black JR; Bamberger DM; Goldman M; Thomas CJ; Gutsch HM; Moskovitz B; Dismukes WE; Kauffman CA
    Clin Infect Dis; 1999 May; 28(5):1049-56. PubMed ID: 10452633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.